+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

From
From
From
Anti-obesity Drugs Market - Product Thumbnail Image

Anti-obesity Drugs Market

  • Report
  • November 2023
  • 67 Pages
  • Global
From
Non-Insulin Diabetes Therapeutics Market 2024-2028 - Product Thumbnail Image

Non-Insulin Diabetes Therapeutics Market 2024-2028

  • Report
  • August 2024
  • 178 Pages
  • Global
From
Anti-Obesity Drugs - Global Strategic Business Report - Product Thumbnail Image

Anti-Obesity Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 264 Pages
  • Global
From
Generic Oncology Sterile Injectable Global Market Report 2024 - Product Thumbnail Image

Generic Oncology Sterile Injectable Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Anti-diabetic Drugs Market - Product Thumbnail Image

Anti-diabetic Drugs Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Type 2 Diabetes Market 2023-2027 - Product Thumbnail Image

Type 2 Diabetes Market 2023-2027

  • Report
  • November 2022
  • 120 Pages
  • Global
From
Loading Indicator